Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Participants in this study.

ICI: immune checkpoint inhibitors, irAE: immune-related adverse event.

More »

Fig 1 Expand

Table 1.

Baseline characteristics of the patients in the study.

More »

Table 1 Expand

Fig 2.

Flow diagram of irAE resumption.

ICI: immune checkpoint inhibitors, irAE: immune-related adverse event.

More »

Fig 2 Expand

Table 2.

Clinical courses of patients with recurring grade ≥2 irAEs after ICI resumption.

More »

Table 2 Expand

Table 3.

Factors associated with the recurrence of grade ≥2 irAEs after ICI resumption.

More »

Table 3 Expand